We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$42.6M
Cap. Flow %
-48.9%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

1 Healthcare 44.7%
2 Consumer Staples 14.06%
3 Consumer Discretionary 4.38%
4 Financials 4.11%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMN icon
326
CALL
Lumen
LUMN
$6.47B
– –
-15,400
Closed -$5K
LUMN icon
327
PUT
Lumen
LUMN
$6.47B
– –
-12,800
Closed -$7K
META icon
328
Meta Platforms (Facebook)
META
$1.64T
– –
-5,800
Closed -$712K
META icon
329
PUT
Meta Platforms (Facebook)
META
$1.64T
– –
-29,900
Closed -$43K
MSFT icon
330
Microsoft
MSFT
$2.93T
– –
-7,657
Closed -$461K
NKE icon
331
CALL
Nike
NKE
$64.9B
– –
-5,000
Closed -$1K
NKE icon
332
Nike
NKE
$64.9B
– –
-184
Closed -$10K
NKE icon
333
PUT
Nike
NKE
$64.9B
– –
-5,000
Closed -$9K
NKTR icon
334
CALL
Nektar Therapeutics
NKTR
$2.31B
– –
-3,333
Closed -$63K
NKTR icon
335
PUT
Nektar Therapeutics
NKTR
$2.31B
– –
-333
Closed -$10K
NTES icon
336
PUT
NetEase
NTES
$84.1B
– –
-50,000
Closed -$5K
NVAX icon
337
Novavax
NVAX
$1.35B
– –
-4,500
Closed -$187K
NVAX icon
338
PUT
Novavax
NVAX
$1.35B
– –
-11,575
Closed -$219K
NXPI icon
339
PUT
NXP Semiconductors
NXPI
$67.3B
– –
-10,600
Closed -$5K
ORCL icon
340
CALL
Oracle
ORCL
$364B
– –
-20,200
Closed -$8K
ORCL icon
341
Oracle
ORCL
$364B
– –
-7,300
Closed -$287K
ORCL icon
342
PUT
Oracle
ORCL
$364B
– –
-42,800
Closed -$113K
OZK icon
343
Bank OZK
OZK
$5.68B
– –
-23,675
Closed -$909K
OZK icon
344
PUT
Bank OZK
OZK
$5.68B
– –
-57,000
Closed -$160K
PBYI icon
345
CALL
Puma Biotechnology
PBYI
$434M
– –
-12,500
Closed -$9K
PBYI icon
346
Puma Biotechnology
PBYI
$434M
– –
-21,338
Closed -$1.43M
PBYI icon
347
PUT
Puma Biotechnology
PBYI
$434M
– –
-21,200
Closed -$36K
PG icon
348
CALL
Procter & Gamble
PG
$349B
– –
-16,000
Closed -$115K
PG icon
349
Procter & Gamble
PG
$349B
– –
-45,000
Closed -$4.04M
PG icon
350
PUT
Procter & Gamble
PG
$349B
– –
-61,500
Closed -$1.23M
12 13
14
15 16

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $42.6M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.